Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Ryvu Therapeutics to Support Clinical Trials for BioNTech in Poland | Contract Pharma
Breaking News, Collaborations & Alliances

Ryvu Therapeutics to Support Clinical Trials for BioNTech in Poland

Will support BioNTech in the acceleration of site activation and enrollment of patients for multiple of BioNTech’s priority oncology clinical programs in Poland.

Ryvu Therapeutics, a clinical-stage drug discovery and development company specializing in novel therapies targeting emerging oncology targets, is entering a strategic partnership with BioNTech to benefit Polish cancer patients by providing support for trial site activation and patient recruitment for multiple investigational immunotherapies within BioNTech’s oncology pipeline in Poland.

Ryvu’s operational excellence, expertise in oncology clinical operations, and existing trial site network will be leveraged to streamline access of Polish patients to BioNTech’s investigational immunotherapies. BioNTech will design and conduct clinical trials for some of its priority programs in Poland and fund Ryvu’s services under the agreement. The clinical programs planned for inclusion in the agreement span various solid tumor types, including lung, breast, and colorectal cancer.

Kamil Sitarz, Chief Operating Officer, Management Board Member of Ryvu Therapeutics, said: “We are thrilled to build on our strong research relationship with BioNTech by entering a strategic agreement that leverages Ryvu’s operational excellence and expertise in oncology clinical operations to bring more BioNTech clinical programs to Poland.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters